Graham Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

Graham Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-178,764	Closed	-$127K	–	1513
2025 Q4	$127K	Buy	+178,764	New	+$243K	﹤0.01%	1122
2024 Q4	–	Sell	-13,962	Closed	-$26.9K	–	1479
2024 Q3	$26.9K	Sell	13,962 -2,265	-14%	-$6.39K	﹤0.01%	1058
2024 Q2	$50.3K	Buy	+16,227	New	+$67K	﹤0.01%	983

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Graham Capital Management's TNYA Position: Q1 2026 in Review

Graham Capital Management sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 178,764 shares — an estimated $127K sold.

Graham Capital Management first reported a position in TNYA in Q2 2024 and held it in 3 quarters. The position peaked at $127K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Graham Capital Management reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
Graham Capital Management sold 178,764 Tenaya Therapeutics shares in Q1 2026, an estimated $127K.
Graham Capital Management first reported a position in Tenaya Therapeutics in Q2 2024 and held it in 3 quarters.
Graham Capital Management's Tenaya Therapeutics position peaked at $127K in Q4 2025.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.